摘要
【目的】观察醒脑开窍针法结合康复训练改善脑卒中后偏瘫患者运动功能和日常生活活动能力的疗效。【方法】将60例脑卒中后偏瘫患者随机分为治疗组和对照组各30例,所有患者均给予常规基础药物治疗,对照组同时给予常规康复训练,治疗组在常规康复训练基础上加用醒脑开窍针刺法治疗,治疗周期为4周,疗程结束后随访至12周。比较2组Fugl-Meyer运动功能评分(FMA)、Barthel指数(MBI)及生存质量评分(SS-QOL)改善情况。【结果】治疗前,2组患者FMA、MBI及SS-QOL评分的基线水平比较,差异均无统计学意义(P>0.05);治疗4周后,2组患者的FMA、MBI及SS-QOL评分均显著提高,差异均有统计学意义(P<0.05),且治疗组效果优于对照组(P<0.05);随访至12周时,2组患者的FMA、MBI及SSQOL评分也均较基线水平显著提高(P<0.05)。【结论】醒脑开窍针法结合康复训练是改善脑卒中后偏瘫患者运动功能和日常生活活动能力的重要手段,作用效果持续,其疗效优于单纯康复训练组。
Objective To observe the therapeutic effect of consciousness-restoring needling combined with comprehensive rehabilitation training on motor function and the activities of daily living of poststroke patients with hemiplegia. Methods Sixty qualified patients were evenly randomized into observation group and control group. All of the patients were given conventional medicine treatment and conventional rehabilitation training,and the treatment group was given consciousness-restoring needling additionally. The therapeutic effects were compared at the end of first session of treatment for 4 weeks and 12 weeks after the first session of treatment. The Fugl-Meyer motor assessment scale（FMA）, modified Barthel Index（MBI） and Stroke-Specific Quality of Life Scale（SS-QQL） were taken as the main evaluation indexes. Results The differences of FMA, MBI and SSQOL scores were insignificant between the two groups before treatment（P〉0.05）. At the end of treatment for 4weeks, FMA, MBI and SS-QOL scores were increased in the two groups（P〈0.05）, and the increase was more obvious in the observation group（P〈0.05）. The results of follow-up till the 12 th week showed that FMA, MBI and SS-QOL scores were still higher than the baseline level（P〈0.05）. Conclusion Consciousness-restoring needling combined with comprehensive rehabilitation training has better effect on improving motor function and the activities of daily living of poststroke hemiplegia patients than comprehensive rehabilitation training alone.
出处
《广州中医药大学学报》
CAS
2015年第4期618-622,共5页
Journal of Guangzhou University of Traditional Chinese Medicine
基金
广东省科技厅科研项目(编号:2011B031700034)
